|
1
|
Fuster V, Rydén LE, Cannom DS, et al: 2011
ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006
Guidelines for the management of patients with atrial fibrillation:
a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines developed in
partnership with the European Society of Cardiology and in
collaboration with the European Heart Rhythm Association and the
Heart Rhythm Society. J Am Coll Cardiol. 57:e101–e198. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilke T, Groth A, Mueller S, et al:
Incidence and prevalence of atrial fibrillation: an analysis based
on 8.3 million patients. Europace. 15:486–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ulasli SS, Ozyurek BA, Yilmaz EB and
Ulubay G: Mean platelet volume as an inflammatory marker in acute
exacerbation of chronic obstructive pulmonary disease. Pol Arch Med
Wewn. 122:284–290. 2012.PubMed/NCBI
|
|
4
|
Braekkan SK, Mathiesen EB, Njølstad I, et
al: Mean platelet volume is a risk factor for venous
thromboembolism: the Tromsø study, Tromsø, Norway. J Thromb
Haemost. 8:157–162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vizioli L, Muscari S and Muscari A: The
relationship of mean platelet volume with the risk and prognosis of
cardiovascular diseases. Int J Clin Pract. 63:1509–1515. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Papanas N, Symeonidis G, Maltezos E, et
al: Mean platelet volume in patients with type 2 diabetes mellitus.
Platelets. 15:475–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hunt SA, Baker DW, Chin MH, et al: ACC/AHA
guidelines for the evaluation and management of chronic heart
failure in the adult: executive summary a report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines (Committee to revise the 1995 guidelines for
the evaluation and management of heart failure): Developed in
collaboration with the International Society for Heart and Lung
Transplant; endorsed by the Heart Failure society of America.
Circulation. 104:2996–3007. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jauch EC, Saver JL, Adams HP Jr, et al:
Guidelines for the early management of patients with acute ischemic
stroke: a guideline for healthcare professionals from the American
Heart Association/American Stroke Association. Stroke. 44:870–947.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gage BF, Waterman AD, Shannon W, Boechler
M, Rich MW and Radford MJ: Validation of clinical classification
schemes for predicting stroke: results from the National Registry
of Atrial Fibrillation. JAMA. 285:2864–2870. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lip GY, Nieuwlaat R, Pisters R, Lane DA
and Crijns HJ: Refining clinical risk stratification for predicting
stroke and thromboembolism in atrial fibrillation using a novel
risk factor-based approach: the euro heart survey on atrial
fibrillation. Chest. 137:263–272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bath P, Algert C, Chapman N and Neal B:
Progress Collaborative Group: Association of mean platelet volume
with risk of stroke among 3134 individuals with history of
cerebrovascular disease. Stroke. 35:622–626. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuce M, Cakici M, Davutoglu V, et al:
Relationship between mean platelet volume and atrial thrombus in
patients with atrial fibrillation. Blood Coagul Fibrinolysis.
21:722–725. 2010.PubMed/NCBI
|
|
13
|
Choudhury A, Chung I, Blann AD and Lip GY:
Platelet surface CD62P and CD63, mean platelet volume and
soluble/platelet P-selectin as indexes of platelet function in
atrial fibrillation: a comparison of healthy control subjects and
disease control subjects in sinus rhythm. J Am Coll Cardiol.
49:1957–1964. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nadar SK, Lip GY and Blann AD: Platelet
morphology, soluble P selectin and platelet P-selectin in acute
ischaemic stroke. The West Birmingham Stroke Project. Thromb
Haemost. 92:1342–1348. 2004.PubMed/NCBI
|
|
15
|
Tekin G, Tekin YK, Sivri N and Yetkin E:
Mean platelet volume in patients with nonvalvular atrial
fibrillation. Blood Coagul Fibrinolysis. 24:537–539. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Varol E: Increased thrombopoietin and mean
platelet volume in patients with ischemic stroke. Clin Appl Thromb
Hemost. 19:342–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alhaji M, Raju M, Al Darazi F, Kakkar A,
Olstein R, Prabhakaran S and Doukky R: Diastolic dysfunction and
left atrial volume mediates embolic stroke in patients with atrial
fibrillation. Stroke. 45 (Suppl 1):ATP1802014.
|
|
18
|
Beinart R, Heist EK, Newell JB, et al:
Left atrial appendage dimensions predict the risk of stroke/TIA in
patients with atrial fibrillation. J Cardiovasc Electrophysiol.
22:10–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Providencia R, Faustino A, Paiva L, et al:
Mean platelet volume is associated with the presence of left atrial
stasis in patients with non-valvular atrial fibrillation. BMC
Cardiovascular Disord. 13:402013. View Article : Google Scholar
|
|
20
|
Erdogan D, Uysal BA, Aksoy F, et al:
Strict heart rate control attenuates prothrombotic state and
platelet activity in patients with non-valvular permanent atrial
fibrillation. Clin Hemorheol Microcirc. 56:219–229. 2014.PubMed/NCBI
|
|
21
|
Chung MK, Martin DO, Sprecher D, et al:
C-reactive protein elevation in patients with atrial arrhythmias:
inflammatory mechanisms and persistence of atrial fibrillation.
Circulation. 104:2886–2891. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gasparyan AY, Ayvazyan L, Mikhailidis DP
and Kitas GD: Mean platelet volume: a link between thrombosis and
inflammation? Curr Pharm Des. 17:47–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Conway DS, Buggins P, Hughes E and Lip GY:
Relationship of interleukin-6 and C-reactive protein to the
prothrombotic state in chronic atrial fibrillation. J Am Coll
Cardiol. 43:2075–2082. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tohgi H, Konno S, Takahashi S, et al:
Activated coagulation/fibrinolysis system and platelet function in
acute thrombotic stroke patients with increased C-reactive protein
levels. Thromb Res. 100:373–379. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sohara H, Amitani S, Kurose M and Miyahara
K: Atrial fibrillation activates platelets and coagulation in a
time-dependent manner: a study in patients with paroxysmal atrial
fibrillation. J Am Coll Cardiol. 29:106–112. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pinho-Gomes AC, Reilly S, Brandes RP and
Casadei B: Targeting inflammation and oxidative stress in atrial
fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a
reductase inhibition with statins. Antioxid Redox Signal.
20:1268–1285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Turfan M, Erdogan E, Ertas G, et al:
Usefulness of mean platelet volume for predicting stroke risk in
atrial fibrillation patients. Blood Coagul Fibrinolysis. 24:55–58.
2013. View Article : Google Scholar : PubMed/NCBI
|
